A citation-based method for searching scientific literature

K Miyamoto, S Khosrof, S E Bursell, R Rohan, T Murata, A C Clermont, L P Aiello, Y Ogura, A P Adamis. Proc Natl Acad Sci U S A 1999
Times Cited: 558







List of co-cited articles
903 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


A central role for inflammation in the pathogenesis of diabetic retinopathy.
Antonia M Joussen, Vassiliki Poulaki, Minh Ly Le, Kan Koizumi, Christina Esser, Hanna Janicki, Ulrich Schraermeyer, Norbert Kociok, Sascha Fauser, Bernd Kirchhof,[...]. FASEB J 2004
819
27

Inflammation in diabetic retinopathy.
Johnny Tang, Timothy S Kern. Prog Retin Eye Res 2011
657
21


Leukocyte-mediated endothelial cell injury and death in the diabetic retina.
A M Joussen, T Murata, A Tsujikawa, B Kirchhof, S E Bursell, A P Adamis. Am J Pathol 2001
398
18

Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.
L P Aiello, R L Avery, P G Arrigg, B A Keyt, H D Jampel, S T Shah, L R Pasquale, H Thieme, M A Iwamoto, J E Park. N Engl J Med 1994
16

Association of vitreous inflammatory factors with diabetic macular edema.
Hideharu Funatsu, Hidetaka Noma, Tatsuya Mimura, Shuichiro Eguchi, Sadao Hori. Ophthalmology 2009
282
15

Diabetic retinopathy.
David A Antonetti, Ronald Klein, Thomas W Gardner. N Engl J Med 2012
976
15

Assessment of Neurotrophins and Inflammatory Mediators in Vitreous of Patients With Diabetic Retinopathy.
Joseph D Boss, Pawan Kumar Singh, Hemang K Pandya, Joaquin Tosi, Chaesik Kim, Asheesh Tewari, Mark S Juzych, Gary W Abrams, Ashok Kumar. Invest Ophthalmol Vis Sci 2017
76
18

Global prevalence and major risk factors of diabetic retinopathy.
Joanne W Y Yau, Sophie L Rogers, Ryo Kawasaki, Ecosse L Lamoureux, Jonathan W Kowalski, Toke Bek, Shih-Jen Chen, Jacqueline M Dekker, Astrid Fletcher, Jakob Grauslund,[...]. Diabetes Care 2012
14

Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema.
David S Boyer, Young Hee Yoon, Rubens Belfort, Francesco Bandello, Raj K Maturi, Albert J Augustin, Xiao-Yan Li, Harry Cui, Yehia Hashad, Scott M Whitcup. Ophthalmology 2014
602
14


Diabetic retinopathy.
Ning Cheung, Paul Mitchell, Tien Yin Wong. Lancet 2010
13

Retinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leukocyte adhesion in vivo.
Antonia M Joussen, Vassiliki Poulaki, Wenying Qin, Bernd Kirchhof, Nicholas Mitsiades, Stanley J Wiegand, John Rudge, George D Yancopoulos, Anthony P Adamis. Am J Pathol 2002
288
12

Müller cell-derived VEGF is essential for diabetes-induced retinal inflammation and vascular leakage.
Juanjuan Wang, Xueliang Xu, Michael H Elliott, Meili Zhu, Yun-Zheng Le. Diabetes 2010
243
11


Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales.
C P Wilkinson, Frederick L Ferris, Ronald E Klein, Paul P Lee, Carl David Agardh, Matthew Davis, Diana Dills, Anselm Kampik, R Pararajasegaram, Juan T Verdaguer. Ophthalmology 2003
11

Müller cells in the healthy and diseased retina.
Andreas Bringmann, Thomas Pannicke, Jens Grosche, Mike Francke, Peter Wiedemann, Serguei N Skatchkov, Neville N Osborne, Andreas Reichenbach. Prog Retin Eye Res 2006
11

Role of Inflammation in Diabetic Retinopathy.
Anne Rübsam, Sonia Parikh, Patrice E Fort. Int J Mol Sci 2018
231
11

Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase-3 activation in a rodent model of diabetic retinopathy.
J Kyle Krady, Anirban Basu, Colleen M Allen, Yuping Xu, Kathryn F LaNoue, Thomas W Gardner, Steven W Levison. Diabetes 2005
383
9

Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema.
Michael J Elman, Lloyd Paul Aiello, Roy W Beck, Neil M Bressler, Susan B Bressler, Allison R Edwards, Frederick L Ferris, Scott M Friedman, Adam R Glassman, Kellee M Miller,[...]. Ophthalmology 2010
918
9

Vascular endothelial growth factor (VEGF)-induced retinal vascular permeability is mediated by intercellular adhesion molecule-1 (ICAM-1).
K Miyamoto, S Khosrof, S E Bursell, Y Moromizato, L P Aiello, Y Ogura, A P Adamis. Am J Pathol 2000
253
9

Association between Aqueous Cytokines and Diabetic Retinopathy Stage.
Hailiang Wu, De-Kuang Hwang, Xudong Song, Yong Tao. J Ophthalmol 2017
59
15


The progress in understanding and treatment of diabetic retinopathy.
Alan W Stitt, Timothy M Curtis, Mei Chen, Reinhold J Medina, Gareth J McKay, Alicia Jenkins, Thomas A Gardiner, Timothy J Lyons, Hans-Peter Hammes, Rafael Simó,[...]. Prog Retin Eye Res 2016
384
9



The importance of glial cells in the homeostasis of the retinal microenvironment and their pivotal role in the course of diabetic retinopathy.
Francesco Saverio Sorrentino, Michael Allkabes, Giulia Salsini, Claudio Bonifazzi, Paolo Perri. Life Sci 2016
58
13

Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy.
Ermelindo C Leal, Ayyakkannu Manivannan, Ken-Ichi Hosoya, Tetsuya Terasaki, José Cunha-Vaz, António Francisco Ambrósio, John V Forrester. Invest Ophthalmol Vis Sci 2007
192
8

Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE.
Quan Dong Nguyen, David M Brown, Dennis M Marcus, David S Boyer, Sunil Patel, Leonard Feiner, Andrea Gibson, Judy Sy, Amy Chen Rundle, J Jill Hopkins,[...]. Ophthalmology 2012
8


Leukocyte adhesion molecules in diabetic retinopathy.
Kousuke Noda, Shintaro Nakao, Susumu Ishida, Tatsuro Ishibashi. J Ophthalmol 2012
66
12



Suppression of Fas-FasL-induced endothelial cell apoptosis prevents diabetic blood-retinal barrier breakdown in a model of streptozotocin-induced diabetes.
Antonia M Joussen, Vassiliki Poulaki, Nicholas Mitsiades, Wen-yi Cai, Izumi Suzuma, John Pak, Shyr-Te Ju, Susan L Rook, Peter Esser, Constantin S Mitsiades,[...]. FASEB J 2003
127
8

Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE.
David M Brown, Quan Dong Nguyen, Dennis M Marcus, David S Boyer, Sunil Patel, Leonard Feiner, Patricio G Schlottmann, Amy Chen Rundle, Jiameng Zhang, Roman G Rubio,[...]. Ophthalmology 2013
533
8

TNF-α signals through PKCζ/NF-κB to alter the tight junction complex and increase retinal endothelial cell permeability.
Célia A Aveleira, Cheng-Mao Lin, Steven F Abcouwer, António F Ambrósio, David A Antonetti. Diabetes 2010
270
7

Pharmacokinetics and pharmacodynamics of a sustained-release dexamethasone intravitreal implant.
Joan-En Chang-Lin, Mayssa Attar, Andrew A Acheampong, Michael R Robinson, Scott M Whitcup, Baruch D Kuppermann, Devin Welty. Invest Ophthalmol Vis Sci 2011
344
7

Early and Long-Term Responses to Anti-Vascular Endothelial Growth Factor Therapy in Diabetic Macular Edema: Analysis of Protocol I Data.
Victor H Gonzalez, Joanna Campbell, Nancy M Holekamp, Szilárd Kiss, Anat Loewenstein, Albert J Augustin, Julia Ma, Allen C Ho, Vaishali Patel, Scott M Whitcup,[...]. Am J Ophthalmol 2016
166
7


Immunological mechanisms in the pathogenesis of diabetic retinopathy.
Anthony P Adamis, Adrienne J Berman. Semin Immunopathol 2008
240
7

Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema.
John A Wells, Adam R Glassman, Allison R Ayala, Lee M Jampol, Lloyd Paul Aiello, Andrew N Antoszyk, Bambi Arnold-Bush, Carl W Baker, Neil M Bressler, David J Browning,[...]. N Engl J Med 2015
868
7

VEGF increases retinal vascular ICAM-1 expression in vivo.
M Lu, V L Perez, N Ma, K Miyamoto, H B Peng, J K Liao, A P Adamis. Invest Ophthalmol Vis Sci 1999
169
7

Diabetic Macular Edema: Pathophysiology and Novel Therapeutic Targets.
Arup Das, Paul G McGuire, Sampathkumar Rangasamy. Ophthalmology 2015
250
7

Baicalein reduces inflammatory process in a rodent model of diabetic retinopathy.
Li-ping Yang, Hui-li Sun, Le-meng Wu, Xiu-juan Guo, Hong-liang Dou, Mark O M Tso, Lin Zhao, Shun-min Li. Invest Ophthalmol Vis Sci 2009
101
7

Diabetic retinopathy: seeing beyond glucose-induced microvascular disease.
David A Antonetti, Alistair J Barber, Sarah K Bronson, Willard M Freeman, Thomas W Gardner, Leonard S Jefferson, Mark Kester, Scot R Kimball, J Kyle Krady, Kathryn F LaNoue,[...]. Diabetes 2006
517
7

Activation of nuclear factor-kappaB induced by diabetes and high glucose regulates a proapoptotic program in retinal pericytes.
Giulio Romeo, Wei-Hua Liu, Veronica Asnaghi, Timothy S Kern, Mara Lorenzi. Diabetes 2002
291
7

Oxidative stress and diabetic complications.
Ferdinando Giacco, Michael Brownlee. Circ Res 2010
7

The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema.
Paul Mitchell, Francesco Bandello, Ursula Schmidt-Erfurth, Gabriele E Lang, Pascale Massin, Reinier O Schlingemann, Florian Sutter, Christian Simader, Gabriela Burian, Ortrud Gerstner,[...]. Ophthalmology 2011
873
6

Diabetic retinopathy and inflammation: novel therapeutic targets.
Sampathkumar Rangasamy, Paul G McGuire, Arup Das. Middle East Afr J Ophthalmol 2012
133
6

Vitreous levels of vascular endothelial growth factor and intercellular adhesion molecule 1 are related to diabetic macular edema.
Hideharu Funatsu, Hidetoshi Yamashita, Kumi Sakata, Hidetaka Noma, Tatsuya Mimura, Motohiro Suzuki, Shuichiro Eguchi, Sadao Hori. Ophthalmology 2005
141
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.